Sanchez Gil, J., Dubois, M., Neirinckx, V., LOMBARD, A., Coppieters't Wallant, N., D'arrigo, P., Isci, D., Aldenhoff, T., Brouwers, B., Lassence, C., ROGISTER, B., Lebrun, M., & Sadzot, C. (2022). Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: a proof-of-principle. Molecular Therapy: Oncolytics. doi:10.1016/j.omto.2022.06.002 Peer Reviewed verified by ORBi |
Isci, D., Veiga, D., Cokaiko, J., LOMBARD, A., Chevigné, A., ROGISTER, B., & Neirinckx, V. (10 April 2022). Study of the ACKR3/CXCR7 receptor in glioblastoma [Poster presentation]. Télévie Seminar, Liège, Belgium. |
Isci, D.* , D'Uonnolo, G.* , Wantz, M., Rogister, B., LOMBARD, A., Chevigné, A., Szpakowska, M., & Neirinckx, V. (28 December 2021). Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma. Cancers, 14 (1), 130. doi:10.3390/cancers14010130 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Sanchez Gil, J., D'arrigo, P., Neirinckx, V., Isci, D., Brouwers, B., LOMBARD, A., Rogister, B., Lebrun, M., & Sadzot, C. (2021). Targeting of CXCR4+ Glioblastoma initiating cells with a retargeted Oncolytic Herpesvirus (oHSV): proof of concept [Paper presentation]. IHW2021: 45th International Herpesvirus Workshop. |
Sanchez Gil, J., D'arrigo, P., Lebrun, M., Isci, D., Coppieters, N., Rogister, B., Chevigné, A., & Sadzot, C. (2021). Targeting of CXCR4+ Glioblastoma initiating cells with a retargeted oncolytic herpesvirus [Poster presentation]. Journée des chercheurs Télévie. |